Kangji Medical Holdings (HKSE:09997) Change In Working Capital : HK$-32 Mil (TTM As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Kangji Medical Holdings Change In Working Capital?

Kangji Medical Holdings's change in working capital for the quarter that ended in Dec. 2024 was HK$-32 Mil.

Kangji Medical Holdings's change in working capital for the fiscal year that ended in Dec. 2024 was HK$-32 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

Kangji Medical Holdings Change In Working Capital Historical Data

The historical data trend for Kangji Medical Holdings's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kangji Medical Holdings Change In Working Capital Chart

Kangji Medical Holdings Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Working Capital

Get a 7-Day Free Trial

-36.07

28.43

-161.77

-50.06

-32.29

Kangji Medical Holdings Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Change In Working Capital	Get a 7-Day Free Trial									-62.42	-24.74	-25.32	-0.37	-31.92

Kangji Medical Holdings Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-32 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

Kangji Medical Holdings Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Kangji Medical Holdings's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Kangji Medical Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Kangji Medical Holdings Ltd (HKSE:09997) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

50J:Germany

Address

No. 1668 Chunjiang East Road, Tonglu Economic Development Zone, Zhejiang Province, Hangzhou, CHN

Website

http://www.kangjimedical.com

Kangji Medical Holdings Ltd is engaged in the production and sales of minimally invasive surgical instruments and accessories. The principal activities of the company are to design, develop, manufacture and sell a comprehensive suite of MISIA that are focused on the surgical specialties of OBGYN, urology, general surgery and thoracic surgery. The company offers a product portfolio to provide physicians and hospitals with one-shop and tailored surgical solutions for four surgical specialties OBGYN, general surgery, urology, and thoracic surgery. It manufactures and sells both disposable and reusable products. Its product portfolio includes disposable trocars, polymer ligation clips, disposable electrocoagulation forceps, It derives the majority of its revenue from Mainland China.

Executives

Tpg Operating Group Ii, L.p.	2201 Interest of corporation controlled by you
Tpg Inc.	2201 Interest of corporation controlled by you
Tpg Gp A, Llc	2201 Interest of corporation controlled by you
Fortune Spring Zm Aa Limited	2101 Beneficial owner
Butterfield Trust (asia) Limited	2301 Trustee
Yg Aa Limited	2201 Interest of corporation controlled by you
Bos Trustee Limited	2201 Interest of corporation controlled by you
Zhong Ming	2501 Other
Fortune Spring Yg B Limited	2101 Beneficial owner
Shentu Yinguang	2501 Other
Fortune Spring Zm B Limited	2101 Beneficial owner
Credit Suisse Trust Limited	2201 Interest of corporation controlled by you
Keyhole Holding Limited	2101 Beneficial owner
Tpg Asia Genpar Vii Advisors, Inc.	2201 Interest of corporation controlled by you
Tpg Asia Genpar Vii, L.p.	2201 Interest of corporation controlled by you

Kangji Medical Holdings Headlines

No Headlines